Transcatheter Aortic Valve Implantation Is An Open Cardiac Operation That Replaces A Narrowed Aortic Valve In A Minimally Invasive Manner.

 

Transcatheter Aortic Valve Implantation

Transcatheter Aortic Valve Implantation is an open cardiac operation that replaces a narrowed aortic valve in a minimally invasive manner. It is employed to treat aortic stenosis. Aortic stenosis is a condition when the aortic valve does not fully open, causing blood flow to be restricted. A huge artery called the aorta delivers blood from the heart to the rest of the body. These high-risk patients are those who are ineligible for surgical aortic valve replacement (SAVR) and cannot be operated on. Older people (those over 75) fall under the high-risk category since having an open heart surgery is too dangerous for them. Transcatheter aortic valve replacement (TAVR) is a procedure that restores the body's capacity for blood circulation.

Patients with severe aortic stenosis have found that Transcatheter Aortic Valve Implantation (TAVR) is the cornerstone treatment (AS). Currently, both rheumatic and non-rheumatic AS are overrepresented in India. A ray of optimism exists for the future of rheumatic AS despite the fact that TAVR has transformed the treatment of non-rheumatic AS. Due to a dearth of epidemiological research in this group, it is challenging to estimate the true burden of AS in India. There are many patients who are eligible for TAVR, according to various estimations. TAVR is still out of the price range of the typical Indian citizen, despite its immense promise. India's TAVR implementation is still moving along quite slowly because of several barriers. These include exorbitant prices, a lack of insurance coverage, and persistent

Paucity of post-TAVR care specialists and sufficient TAVR operators with the necessary training. Furthermore, particular anatomical characteristics like a smaller body surface area, a smaller annulus, a low coronary ostia take-off, a smaller iliac and common femoral artery calibre, and a smaller body surface area all present unique challenges in terms of the need for smaller hardware and increased complication risks. Policymakers and healthcare professionals must recognise the advantages of this breakthrough and take the necessary action to facilitate the adoption of TAVR throughout the nation.

The minimally invasive surgical treatment known as Transcatheter Aortic Valve Implantation (TAVI), sometimes known as transcatheter aortic valve replacement (TAVR), is used to treat high-risk patients with aortic stenosis. Open cardiac surgery can be used to replace the aortic valve. Breathlessness, chest pain, dizziness, and swollen ankles can all be symptoms of aortic stenosis, a condition where the aortic valve cannot open and seal properly. A long, narrow tube known as a catheter is used to implant an aortic valve during transcatheter aortic valve implantation. For elderly or feeble patients, TAVI is more practical than a traditional valve replacement. Transcatheter aortic valve implantation (TAV) entails restoring the aortic valve's capacity for blood flow. Transcatheter aortic valve replacement is necessary.